Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-09-30

AUTHORS

S Kumar, C C Pan, J C Bloodworth, A B Nixon, C Theuer, D G Hoyt, N Y Lee

ABSTRACT

Endoglin is a transforming growth factor β (TGF-β) coreceptor that serves as a prognostic, diagnostic and therapeutic vascular target in human cancer. A number of endoglin ectodomain-targeting antibodies (Abs) can effectively suppress both normal and tumor-associated angiogenesis, but their molecular actions remain poorly characterized. Here we define a key mechanism for TRACON105 (TRC105), a humanized monoclonal Ab in clinical trials for treatment of advanced or metastatic tumors. TRC105, along with several other endoglin Abs tested, enhance endoglin shedding through direct coupling of endoglin and the membrane-type 1 matrix metalloproteinase (MMP)-14 at the cell surface to release the antiangiogenic factor, soluble endoglin (sEng). In addition to this coupling process, endoglin shedding is further amplified by increased MMP-14 expression that requires TRC105 concentration-dependent c-Jun N-terminal kinase (JNK) activation. There were also notable counterbalancing effects on canonical Smad signaling in which TRC105 abrogated both the steady-state and TGF-β-induced Smad1/5/8 activation while augmenting Smad2/3 activation. Interestingly, TRC105-induced sEng and aberrant Smad signaling resulted in an excessive migratory response through enhanced stress fiber formation and disruption of endothelial cell–cell junctions. Collectively, our study defines endoglin shedding and deregulated TGF-β signaling during migration as major mechanisms by which TRC105 inhibits angiogenesis. More... »

PAGES

3970-3979

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/onc.2013.386

DOI

http://dx.doi.org/10.1038/onc.2013.386

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1025649013

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24077288


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiogenesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, CD", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "COS Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Membrane", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Movement", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chlorocebus aethiops", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Screening Assays, Antitumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endoglin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Human Umbilical Vein Endothelial Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Matrix Metalloproteinase 14", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neovascularization, Pathologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Transport", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proteolysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Cell Surface", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Smad Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transforming Growth Factor beta", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kumar", 
        "givenName": "S", 
        "id": "sg:person.013752006730.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013752006730.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pan", 
        "givenName": "C C", 
        "id": "sg:person.01156455135.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156455135.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bloodworth", 
        "givenName": "J C", 
        "id": "sg:person.0614346745.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614346745.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke Cancer Institute, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke Cancer Institute, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nixon", 
        "givenName": "A B", 
        "id": "sg:person.01055010121.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055010121.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "TRACON Pharmaceuticals, San Diego, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.430777.0", 
          "name": [
            "TRACON Pharmaceuticals, San Diego, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Theuer", 
        "givenName": "C", 
        "id": "sg:person.01067332740.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067332740.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoyt", 
        "givenName": "D G", 
        "id": "sg:person.01242743756.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242743756.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Davis Heart and Lung Research Institute, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA", 
            "Davis Heart and Lung Research Institute, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "N Y", 
        "id": "sg:person.0700265242.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700265242.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1741-7015-8-86", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037796341", 
          "https://doi.org/10.1186/1741-7015-8-86"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1159/000097040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023787655", 
          "https://doi.org/10.1159/000097040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1203991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014358593", 
          "https://doi.org/10.1038/sj.onc.1203991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.2537", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031152422", 
          "https://doi.org/10.1038/nm.2537"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-09-30", 
    "datePublishedReg": "2013-09-30", 
    "description": "Endoglin is a transforming growth factor \u03b2 (TGF-\u03b2) coreceptor that serves as a prognostic, diagnostic and therapeutic vascular target in human cancer. A number of endoglin ectodomain-targeting antibodies (Abs) can effectively suppress both normal and tumor-associated angiogenesis, but their molecular actions remain poorly characterized. Here we define a key mechanism for TRACON105 (TRC105), a humanized monoclonal Ab in clinical trials for treatment of advanced or metastatic tumors. TRC105, along with several other endoglin Abs tested, enhance endoglin shedding through direct coupling of endoglin and the membrane-type 1 matrix metalloproteinase (MMP)-14 at the cell surface to release the antiangiogenic factor, soluble endoglin (sEng). In addition to this coupling process, endoglin shedding is further amplified by increased MMP-14 expression that requires TRC105 concentration-dependent c-Jun N-terminal kinase (JNK) activation. There were also notable counterbalancing effects on canonical Smad signaling in which TRC105 abrogated both the steady-state and TGF-\u03b2-induced Smad1/5/8 activation while augmenting Smad2/3 activation. Interestingly, TRC105-induced sEng and aberrant Smad signaling resulted in an excessive migratory response through enhanced stress fiber formation and disruption of endothelial cell\u2013cell junctions. Collectively, our study defines endoglin shedding and deregulated TGF-\u03b2 signaling during migration as major mechanisms by which TRC105 inhibits angiogenesis.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/onc.2013.386", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2442105", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3534966", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438807", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "30", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "keywords": [
      "MMP-14 expression", 
      "tumor-associated angiogenesis", 
      "soluble endoglin", 
      "c-Jun N-terminal kinase (JNK) activation", 
      "metastatic tumors", 
      "clinical trials", 
      "antiangiogenic factors", 
      "matrix metalloproteinase", 
      "vascular targets", 
      "Smad2/3 activation", 
      "endoglin", 
      "monoclonal Ab", 
      "inhibits angiogenesis", 
      "MMP-14", 
      "Smad signaling", 
      "enhanced stress fiber formation", 
      "human cancers", 
      "migratory response", 
      "molecular actions", 
      "Smad1/5/8 activation", 
      "canonical Smad", 
      "TRC105", 
      "key mechanism", 
      "angiogenesis", 
      "activation", 
      "kinase activation", 
      "stress fiber formation", 
      "major mechanism", 
      "cell surface", 
      "endothelial cell-cell junctions", 
      "tumors", 
      "cancer", 
      "TGF", 
      "coreceptor", 
      "trials", 
      "metalloproteinase", 
      "antibodies", 
      "Ab", 
      "treatment", 
      "sEng", 
      "Smad", 
      "signaling", 
      "mechanism", 
      "fiber formation", 
      "expression", 
      "cell-cell junctions", 
      "disruption", 
      "response", 
      "target", 
      "factors", 
      "action", 
      "deregulation", 
      "effect", 
      "migration", 
      "junction", 
      "addition", 
      "number", 
      "formation", 
      "coupling process", 
      "process", 
      "direct coupling", 
      "surface", 
      "coupling"
    ], 
    "name": "Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-\u03b2 signaling", 
    "pagination": "3970-3979", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1025649013"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/onc.2013.386"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24077288"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/onc.2013.386", 
      "https://app.dimensions.ai/details/publication/pub.1025649013"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_583.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/onc.2013.386"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/onc.2013.386'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/onc.2013.386'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/onc.2013.386'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/onc.2013.386'


 

This table displays all metadata directly associated to this object as RDF triples.

280 TRIPLES      21 PREDICATES      113 URIs      100 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/onc.2013.386 schema:about N0597af34c3ae43f7bb3a80209bf78fb4
2 N07c4904a20294a09b0e694283b79e710
3 N16808a3cc3ee4f5b9e61436365c7079a
4 N17cb4edd54c245f195345b49b74947ab
5 N263683440e924ce9af5ad1033226f039
6 N297e794ac67f4fe7a8ae49ed417dbdf3
7 N2d1b5f6edd1c4ad09d81e837d95efcc5
8 N39a818f62c71442e90f8e416b3ee0ab9
9 N5d0bc42182b348b384baa91f92e8cccc
10 N751a5be4092b4c0aaf31dc340a8d4425
11 N768da03e13df4de3a3a5728831f3bf1a
12 N8e2e8666f5fa4e7285c3832337bb9391
13 N91d67ef7e16a4be9a2e17977825eeeca
14 Naa58bb79c71949dd99eecc63f4ffaed2
15 Nbfa7c6ce419f456ab058549477ac5cc3
16 Nc20345219f3b4d70b7787a85de302744
17 Nc466614e4ef848f88e493ba7517d45de
18 Ncce60923e8684473addfe04639305786
19 Nd87660e820024ff1bc73fd604ee02e2b
20 Nff62f167bf814458b63810372b8f766c
21 anzsrc-for:11
22 anzsrc-for:1103
23 anzsrc-for:1112
24 schema:author N1774ca5b0f874329a90ca326eb651b19
25 schema:citation sg:pub.10.1038/nm.2537
26 sg:pub.10.1038/sj.onc.1203991
27 sg:pub.10.1159/000097040
28 sg:pub.10.1186/1741-7015-8-86
29 schema:datePublished 2013-09-30
30 schema:datePublishedReg 2013-09-30
31 schema:description Endoglin is a transforming growth factor β (TGF-β) coreceptor that serves as a prognostic, diagnostic and therapeutic vascular target in human cancer. A number of endoglin ectodomain-targeting antibodies (Abs) can effectively suppress both normal and tumor-associated angiogenesis, but their molecular actions remain poorly characterized. Here we define a key mechanism for TRACON105 (TRC105), a humanized monoclonal Ab in clinical trials for treatment of advanced or metastatic tumors. TRC105, along with several other endoglin Abs tested, enhance endoglin shedding through direct coupling of endoglin and the membrane-type 1 matrix metalloproteinase (MMP)-14 at the cell surface to release the antiangiogenic factor, soluble endoglin (sEng). In addition to this coupling process, endoglin shedding is further amplified by increased MMP-14 expression that requires TRC105 concentration-dependent c-Jun N-terminal kinase (JNK) activation. There were also notable counterbalancing effects on canonical Smad signaling in which TRC105 abrogated both the steady-state and TGF-β-induced Smad1/5/8 activation while augmenting Smad2/3 activation. Interestingly, TRC105-induced sEng and aberrant Smad signaling resulted in an excessive migratory response through enhanced stress fiber formation and disruption of endothelial cell–cell junctions. Collectively, our study defines endoglin shedding and deregulated TGF-β signaling during migration as major mechanisms by which TRC105 inhibits angiogenesis.
32 schema:genre article
33 schema:isAccessibleForFree true
34 schema:isPartOf N96ac8e56eba047e18cd8a4a424451d1c
35 Nfdeb81d7b23446aa87564e1b1d3fc1e8
36 sg:journal.1097543
37 schema:keywords Ab
38 MMP-14
39 MMP-14 expression
40 Smad
41 Smad signaling
42 Smad1/5/8 activation
43 Smad2/3 activation
44 TGF
45 TRC105
46 action
47 activation
48 addition
49 angiogenesis
50 antiangiogenic factors
51 antibodies
52 c-Jun N-terminal kinase (JNK) activation
53 cancer
54 canonical Smad
55 cell surface
56 cell-cell junctions
57 clinical trials
58 coreceptor
59 coupling
60 coupling process
61 deregulation
62 direct coupling
63 disruption
64 effect
65 endoglin
66 endothelial cell-cell junctions
67 enhanced stress fiber formation
68 expression
69 factors
70 fiber formation
71 formation
72 human cancers
73 inhibits angiogenesis
74 junction
75 key mechanism
76 kinase activation
77 major mechanism
78 matrix metalloproteinase
79 mechanism
80 metalloproteinase
81 metastatic tumors
82 migration
83 migratory response
84 molecular actions
85 monoclonal Ab
86 number
87 process
88 response
89 sEng
90 signaling
91 soluble endoglin
92 stress fiber formation
93 surface
94 target
95 treatment
96 trials
97 tumor-associated angiogenesis
98 tumors
99 vascular targets
100 schema:name Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling
101 schema:pagination 3970-3979
102 schema:productId N00db914f5a6d47ab827108d3181f5a3b
103 N456459f2ad5d441495fe58222bda1a73
104 Ndf57578690f642778115631fd5e6e212
105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025649013
106 https://doi.org/10.1038/onc.2013.386
107 schema:sdDatePublished 2022-11-24T20:56
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher N6a31d9ea46cd47988383af3de6857f29
110 schema:url https://doi.org/10.1038/onc.2013.386
111 sgo:license sg:explorer/license/
112 sgo:sdDataset articles
113 rdf:type schema:ScholarlyArticle
114 N00db914f5a6d47ab827108d3181f5a3b schema:name dimensions_id
115 schema:value pub.1025649013
116 rdf:type schema:PropertyValue
117 N032c2f78baf64441bef868d6ddb6dc41 rdf:first sg:person.01242743756.91
118 rdf:rest N9c36d322494a48a99ebd18e5b3fb961c
119 N0597af34c3ae43f7bb3a80209bf78fb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Human Umbilical Vein Endothelial Cells
121 rdf:type schema:DefinedTerm
122 N07c4904a20294a09b0e694283b79e710 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Neovascularization, Pathologic
124 rdf:type schema:DefinedTerm
125 N16808a3cc3ee4f5b9e61436365c7079a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Angiogenesis Inhibitors
127 rdf:type schema:DefinedTerm
128 N1774ca5b0f874329a90ca326eb651b19 rdf:first sg:person.013752006730.81
129 rdf:rest N570fc69a61f546e6aac41d2474d37827
130 N17cb4edd54c245f195345b49b74947ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Animals
132 rdf:type schema:DefinedTerm
133 N263683440e924ce9af5ad1033226f039 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Smad Proteins
135 rdf:type schema:DefinedTerm
136 N297e794ac67f4fe7a8ae49ed417dbdf3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name COS Cells
138 rdf:type schema:DefinedTerm
139 N2d1b5f6edd1c4ad09d81e837d95efcc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Humans
141 rdf:type schema:DefinedTerm
142 N3192910791bf42c0ab78628746681b75 rdf:first sg:person.01055010121.15
143 rdf:rest Nafa241acbfcf41f18e2723d8a178321e
144 N39a818f62c71442e90f8e416b3ee0ab9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Transforming Growth Factor beta
146 rdf:type schema:DefinedTerm
147 N456459f2ad5d441495fe58222bda1a73 schema:name pubmed_id
148 schema:value 24077288
149 rdf:type schema:PropertyValue
150 N570fc69a61f546e6aac41d2474d37827 rdf:first sg:person.01156455135.46
151 rdf:rest Nfb97be6c5bbd4920a88e5f99a346466a
152 N5d0bc42182b348b384baa91f92e8cccc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Cell Movement
154 rdf:type schema:DefinedTerm
155 N6a31d9ea46cd47988383af3de6857f29 schema:name Springer Nature - SN SciGraph project
156 rdf:type schema:Organization
157 N751a5be4092b4c0aaf31dc340a8d4425 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Protein Transport
159 rdf:type schema:DefinedTerm
160 N768da03e13df4de3a3a5728831f3bf1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Antibodies, Monoclonal
162 rdf:type schema:DefinedTerm
163 N8e2e8666f5fa4e7285c3832337bb9391 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Drug Screening Assays, Antitumor
165 rdf:type schema:DefinedTerm
166 N91d67ef7e16a4be9a2e17977825eeeca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Chlorocebus aethiops
168 rdf:type schema:DefinedTerm
169 N96ac8e56eba047e18cd8a4a424451d1c schema:issueNumber 30
170 rdf:type schema:PublicationIssue
171 N9c36d322494a48a99ebd18e5b3fb961c rdf:first sg:person.0700265242.30
172 rdf:rest rdf:nil
173 Naa58bb79c71949dd99eecc63f4ffaed2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Receptors, Cell Surface
175 rdf:type schema:DefinedTerm
176 Nafa241acbfcf41f18e2723d8a178321e rdf:first sg:person.01067332740.24
177 rdf:rest N032c2f78baf64441bef868d6ddb6dc41
178 Nbfa7c6ce419f456ab058549477ac5cc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Cell Membrane
180 rdf:type schema:DefinedTerm
181 Nc20345219f3b4d70b7787a85de302744 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Proteolysis
183 rdf:type schema:DefinedTerm
184 Nc466614e4ef848f88e493ba7517d45de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Signal Transduction
186 rdf:type schema:DefinedTerm
187 Ncce60923e8684473addfe04639305786 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Antigens, CD
189 rdf:type schema:DefinedTerm
190 Nd87660e820024ff1bc73fd604ee02e2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Matrix Metalloproteinase 14
192 rdf:type schema:DefinedTerm
193 Ndf57578690f642778115631fd5e6e212 schema:name doi
194 schema:value 10.1038/onc.2013.386
195 rdf:type schema:PropertyValue
196 Nfb97be6c5bbd4920a88e5f99a346466a rdf:first sg:person.0614346745.36
197 rdf:rest N3192910791bf42c0ab78628746681b75
198 Nfdeb81d7b23446aa87564e1b1d3fc1e8 schema:volumeNumber 33
199 rdf:type schema:PublicationVolume
200 Nff62f167bf814458b63810372b8f766c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Endoglin
202 rdf:type schema:DefinedTerm
203 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
204 schema:name Medical and Health Sciences
205 rdf:type schema:DefinedTerm
206 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
207 schema:name Clinical Sciences
208 rdf:type schema:DefinedTerm
209 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
210 schema:name Oncology and Carcinogenesis
211 rdf:type schema:DefinedTerm
212 sg:grant.2438807 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2013.386
213 rdf:type schema:MonetaryGrant
214 sg:grant.2442105 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2013.386
215 rdf:type schema:MonetaryGrant
216 sg:grant.3534966 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2013.386
217 rdf:type schema:MonetaryGrant
218 sg:journal.1097543 schema:issn 0950-9232
219 1476-5594
220 schema:name Oncogene
221 schema:publisher Springer Nature
222 rdf:type schema:Periodical
223 sg:person.01055010121.15 schema:affiliation grid-institutes:grid.26009.3d
224 schema:familyName Nixon
225 schema:givenName A B
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055010121.15
227 rdf:type schema:Person
228 sg:person.01067332740.24 schema:affiliation grid-institutes:grid.430777.0
229 schema:familyName Theuer
230 schema:givenName C
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067332740.24
232 rdf:type schema:Person
233 sg:person.01156455135.46 schema:affiliation grid-institutes:grid.261331.4
234 schema:familyName Pan
235 schema:givenName C C
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156455135.46
237 rdf:type schema:Person
238 sg:person.01242743756.91 schema:affiliation grid-institutes:grid.261331.4
239 schema:familyName Hoyt
240 schema:givenName D G
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242743756.91
242 rdf:type schema:Person
243 sg:person.013752006730.81 schema:affiliation grid-institutes:grid.261331.4
244 schema:familyName Kumar
245 schema:givenName S
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013752006730.81
247 rdf:type schema:Person
248 sg:person.0614346745.36 schema:affiliation grid-institutes:grid.261331.4
249 schema:familyName Bloodworth
250 schema:givenName J C
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614346745.36
252 rdf:type schema:Person
253 sg:person.0700265242.30 schema:affiliation grid-institutes:grid.261331.4
254 schema:familyName Lee
255 schema:givenName N Y
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700265242.30
257 rdf:type schema:Person
258 sg:pub.10.1038/nm.2537 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031152422
259 https://doi.org/10.1038/nm.2537
260 rdf:type schema:CreativeWork
261 sg:pub.10.1038/sj.onc.1203991 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014358593
262 https://doi.org/10.1038/sj.onc.1203991
263 rdf:type schema:CreativeWork
264 sg:pub.10.1159/000097040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023787655
265 https://doi.org/10.1159/000097040
266 rdf:type schema:CreativeWork
267 sg:pub.10.1186/1741-7015-8-86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037796341
268 https://doi.org/10.1186/1741-7015-8-86
269 rdf:type schema:CreativeWork
270 grid-institutes:grid.26009.3d schema:alternateName Duke Cancer Institute, Durham, NC, USA
271 schema:name Duke Cancer Institute, Durham, NC, USA
272 rdf:type schema:Organization
273 grid-institutes:grid.261331.4 schema:alternateName Davis Heart and Lung Research Institute, Columbus, OH, USA
274 Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA
275 schema:name Davis Heart and Lung Research Institute, Columbus, OH, USA
276 Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA
277 rdf:type schema:Organization
278 grid-institutes:grid.430777.0 schema:alternateName TRACON Pharmaceuticals, San Diego, CA, USA
279 schema:name TRACON Pharmaceuticals, San Diego, CA, USA
280 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...